Ozempic & Mounjaro: Benefits, Risks, and What You Should Know About GLP-1s

Ozempic and Mounjaro are everywhere right now — but what are GLP-1 medications actually doing in the body? In this episode, we break down the science behind GLP-1 receptor agonists, including semaglutide and tirzepatide, and explain how these medications impact appetite, insulin resistance, blood sugar, and weight loss. You’ll learn: • What GLP-1 medications are and how they work• The difference between Ozempic, Wegovy, and Mounjaro• How these drugs affect insulin, gastric emptying, and hunger signals• Potential side effects and long-term considerations• Who may benefit from medical weight loss support• Why medication is a tool, not a substitute for metabolic health This episode offers a balanced, evidence-based discussion of GLP-1 medications — cutting through hype and fear to focus on physiology and appropriate use. If you’re considering Ozempic, Mounjaro, or other weight loss medications, this episode will help you understand the risks, benefits, and long-term strategy.